FNKCX | VMVAX | FNKCX / VMVAX | |
Total Expense Ratio | 2.14 | 0.07 | 3,057% |
Annual Report Gross Expense Ratio | 2.14 | 0.07 | 3,057% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 14.513 | 6.339 | 229% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31M | 32.5B | 0% |
Annual Yield % from dividends | 0.29 | 2.17 | 13% |
Returns for 1 year | 14.26 | 1.20 | 1,185% |
Returns for 3 years | 34.40 | 36.10 | 95% |
Returns for 5 years | 37.14 | 63.10 | 59% |
Returns for 10 years | 25.90 | 99.51 | 26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SVIX | 18.49 | 1.32 | +7.72% |
-1x Short VIX Futures ETF | |||
MOAT | 100.38 | 0.67 | +0.67% |
VanEck Morningstar Wide Moat ETF | |||
BDCX | 22.86 | N/A | N/A |
ETRACS Qrtly Py 1.5X Lvgd Wls Fg BDC ETN | |||
PCEM | 10.97 | N/A | N/A |
Polen Capital Em Mkts ex-China Gr ETF | |||
GSSC | 74.04 | -0.31 | -0.41% |
Goldman Sachs ActiveBeta® US SmCp Eq ETF |